retatrutide glucagon agonist ly3437943 triple glp-1 gip mechanism Beyond GLP-1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based What Is Retatrutide (RETA)? The
Pay in 4 interest-free payments of $5.92 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27








:max_bytes(150000):strip_icc()/health-GettyImages-1340013135-64ee8863eb944cb2a0c308eee92f5bd2.jpg)














